78 related articles for article (PubMed ID: 7521438)
1. [Cardiovascular complications of interferon therapy in chronic hepatitis C].
Kouno H; Aimitsu S; Ikemoto Y; Nakanishi T; Kajiyama G
Nihon Rinsho; 1994 Jul; 52(7):1914-8. PubMed ID: 7521438
[TBL] [Abstract][Full Text] [Related]
2. [Depression during interferon therapy in chronic hepatitis C patients--a prospective study].
Otsubo T; Miyaoka H; Kamijima K; Onuki M; Ishii M; Mitamura K
Seishin Shinkeigaku Zasshi; 1997; 99(3):101-27. PubMed ID: 9136611
[TBL] [Abstract][Full Text] [Related]
3. [Interstitial pneumonia induced by interferon therapy in type C hepatitis].
Karino Y; Hige S; Matsushima T; Toyota J
Nihon Rinsho; 1994 Jul; 52(7):1905-9. PubMed ID: 7521437
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
5. [Interferon-associated retinopathy].
Okuno H; Hirota T; Shiozaki Y; Inoue K; Hagihara M; Sugasawa K; Okami T
Nihon Rinsho; 1994 Jul; 52(7):1919-23. PubMed ID: 7521439
[TBL] [Abstract][Full Text] [Related]
6. [Long-term prognosis of the interferon-treated patients with chronic hepatitis C: compared with the natural course].
Shimomura H; Ito T; Tsuji T
Nihon Rinsho; 1994 Jul; 52(7):1836-40. PubMed ID: 7521427
[TBL] [Abstract][Full Text] [Related]
7. [Effectiveness of interferon, glycyrrhizin combination therapy in patients with chronic hepatitis C].
Abe Y; Ueda T; Kato T; Kohli Y
Nihon Rinsho; 1994 Jul; 52(7):1817-22. PubMed ID: 7521424
[TBL] [Abstract][Full Text] [Related]
8. [Immune status of patients with cardiac arrhythmias: idiopathic and in primary heart disease].
Bekbosynova MS; Pichugin AV; Novikova DS; Gabrusenko SA; Kozhemiakina ESh; Ataullakhanova DM; Golitsyn SP; Ataullakhanov RI
Ter Arkh; 2006; 78(9):52-60. PubMed ID: 17076226
[TBL] [Abstract][Full Text] [Related]
9. [Glucose intolerance during interferon therapy in patients with chronic hepatitis type C].
Ishigami Y; Kanda T; Wada M; Shimizu Y
Nihon Rinsho; 1994 Jul; 52(7):1901-4. PubMed ID: 7521436
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
[TBL] [Abstract][Full Text] [Related]
11. Prolonged-interferon therapy reduces hepatocarcinogenesis in aged-patients with chronic hepatitis C.
Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
J Med Virol; 2007 Aug; 79(8):1095-102. PubMed ID: 17597485
[TBL] [Abstract][Full Text] [Related]
12. [Long-term prognosis after interferon therapy in chronic hepatitis type C].
Inoue O; Yano M
Nihon Rinsho; 1994 Jul; 52(7):1828-31. PubMed ID: 7521425
[TBL] [Abstract][Full Text] [Related]
13. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
14. [Study for relapse cases of chronic hepatitis C treated with interferon (IFN) and approach to more successful re-treatment of IFN].
Iwabuchi S; Yoshida H; Fukui S
Nihon Rinsho; 1994 Jul; 52(7):1810-6. PubMed ID: 7521423
[TBL] [Abstract][Full Text] [Related]
15. IFN/RBV treatment induced neutropenia and its correction with neupogen in patients with hepatitis C.
Sharvadze L; Gochitashvili N; Tophuria A; Bolokadze N; Tsertsvadze T
Georgian Med News; 2007 Jun; (147):52-5. PubMed ID: 17660602
[TBL] [Abstract][Full Text] [Related]
16. [Autoimmune disorders in interferon therapy].
Okanoue T; Itoh Y; Yasui K
Nihon Rinsho; 1994 Jul; 52(7):1924-8. PubMed ID: 7521440
[TBL] [Abstract][Full Text] [Related]
17. Association of genetic polymorphisms with interferon-induced haematologic adverse effects in chronic hepatitis C patients.
Wada M; Marusawa H; Yamada R; Nasu A; Osaki Y; Kudo M; Nabeshima M; Fukuda Y; Chiba T; Matsuda F
J Viral Hepat; 2009 Jun; 16(6):388-96. PubMed ID: 19200137
[TBL] [Abstract][Full Text] [Related]
18. Treatment of chronic hepatitis C with lymphoblastoid interferon alpha in elderly patients.
Terranova R; Luca S
Eur Rev Med Pharmacol Sci; 1997; 1(1-3):47-52. PubMed ID: 9444798
[TBL] [Abstract][Full Text] [Related]
19. Early loss of serum hepatitis C virus RNA can predict a sustained response to interferon therapy in patients with chronic hepatitis C.
Karino Y; Toyota J; Sugawara M; Higashino K; Sato T; Ohmura T; Suga T; Okuuchi Y; Matsushima T
Am J Gastroenterol; 1997 Jan; 92(1):61-5. PubMed ID: 8995939
[TBL] [Abstract][Full Text] [Related]
20. Coronary vasospasm-induced acute coronary syndrome complicated by life-threatening cardiac arrhythmias in patients without hemodynamically significant coronary artery disease.
Hung MJ; Cheng CW; Yang NI; Hung MY; Cherng WJ
Int J Cardiol; 2007 Apr; 117(1):37-44. PubMed ID: 16844245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
